Monday, January 12, 2004 1:16:39 PM
The question is simple. Are you saying the Orchid option has run out or not in regards to Retinome?
-The window starts when IP is presented by DNAP.
-IP usually refers to issued patents.
-DNAP has no patents issued yet.
The question is clear, the assumptions are straightforward. What is the problem?
regards,
frog
p.s. Don't worry about my life, I'm fine. I and my colleagues design and develop lifesaving medical devices that intervene in life threatening situations. There are thousands of people walking this earth today who wouldn't be if not for our efforts. I have no problems with my life choices. Good luck with yours.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM